Lifecare semi-annual report – strategic measures lead to strong increase in external revenue and increased operational capacity

Bergen, 25 August 2022. 

Today, Lifecare present strong financial results following the first half-year
with operational activities in two German subsidiaries as part of the Lifecare
Group. The external revenue in 1H 2022 reached a total of 8,7MNOK, representing
an increase of +8,7MNOK from 1H 2021 (from 0,0 MNOK) and +7,1MNOK from EY 2021
(from 1,6MNOK). A steep increase in operational activities in the Lifecare Group
led to increases in salaries and other operational activities. 

The successful integration of operational subsidiaries in Germany has led to
increased operational capacity. The restructured organization has proved its
capacity and efficiency achieving the major technical milestones of (1)
reproducible and stable in-vitro testing of miniaturized prototype-sensors and
(2) initiation of first-in-human clinical pilot study, as announced in June
2022. 

Lifecare's semi-annual report is available for downloading here:
https://lifecare.no/reports/semi-annual-report-2022/

Lifecare AS will host an online presentation of the 1H 2022 semi-annual results
today (25 August) at 13:00 - 14:00 CET. All shareholders and other interested
parties are welcome to participate in the webcast. Lifecare CEO Joacim Holter
will present H1 2022 financial results and company status and will together with
Lifecare CSO Prof. Andreas Pfützner be available in a Q&A session following the
presentation.
 
The webcast will be available here:
https://teams.microsoft.com/l/meetup-join/19%3ameeting_Mzg3OTJmNDUtMmVmYS00NWZhL
TkzMjctOTFiNWZmZTZhYTk2%40thread.v2/0?context=%7b%22Tid%22%3a%22c5fbb1c6-4eb0-45
db-9f3c-6e20ebcd710e%22%2c%22Oid%22%3a%22e067d101-8c82-4495-b6ce-29a800accfd6%22
%7d
  
Questions can be posted during the event or send in advance to: post@lifecare.no

Contact: 
Joacim Holter, CEO, tel. +47 40059050, epost: joacim.holter@lifecare.no


This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act. This stock exchange announcement was
published by Joacim Holter, Lifecare CEO, on 25 August 2022 at 08:30 CET.